A New Approach towards Anti-Cancer Drugs

by Medindia Content Team on  July 25, 2006 at 9:20 PM Cancer News
RSS Email Print This Page Comment
Font : A-A+

A New Approach towards Anti-Cancer Drugs
According to the researchers at the Edinburgh University anti cancer drugs should be aimed at preventing MDM2 from destroying p53 molecule. MDM2 is a protein which destroys p53 due to a biochemical imbalance inside the cell.

p53 is the guardian protein and is the tumor suppressor protein. Hence the lead researcher Dr. Kathryn Ball said that anti cancer drugs should be targeted against the MDM2 protein. The study has also pointed out a number of protein fragments which has the ability to bind to the MDM2 protein and inhibit its activity as a cancer promoting catalyst.

This study is being sponsored by the Cancer Research UK. Prof. John Toy, medical director of this organization said that p53 plays a crucial role in conserving stability by preventing genome mutation. Hence he said that if the protein is allowed to perform its function without the interference of the MDM2 protein then this would prevent many types of cancer.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions
sunny1 Wednesday, July 26, 2006

P53 is the guardian of the human genome. MDM2 destroys the P53 hence it is only logical to prevent this. This has been known now for sometime.

More News on:

Drug Toxicity Signature Drug Toxicity Top 10 Health Benefits of Cloves 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive